These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma. Lee DA, Ratner D. Dermatol Surg; 2006 Jul; 32(7):916-22; discussion 922-3. PubMed ID: 16875474 [Abstract] [Full Text] [Related]
23. Indications and limitations of Mohs micrographic surgery. Lang PG, Osguthorpe JD. Dermatol Clin; 1989 Oct; 7(4):627-44. PubMed ID: 2676282 [Abstract] [Full Text] [Related]
24. Cost effectiveness of Mohs micrographic surgery: review of the literature. Tierney EP, Hanke CW. J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120 [Abstract] [Full Text] [Related]
27. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Bialy TL, Whalen J, Veledar E, Lafreniere D, Spiro J, Chartier T, Chen SC. Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467 [Abstract] [Full Text] [Related]
28. Mohs micrographic surgery for the management of nonmelanoma skin cancers. Cumberland L, Dana A, Liegeois N. Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914 [Abstract] [Full Text] [Related]
29. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy. Holmkvist KA, Rogers GS, Dahl PR. J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384 [Abstract] [Full Text] [Related]